@article{140beaf9f61c43e1ab8be0b400366c31,
title = "Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: A latent transition analysis of the CIDUS 3/DUIT study",
abstract = "We analyzed data from a large randomized HIV/HCV prevention intervention trial with young injection drug users (IDUs) conducted in five U.S. cities. The trial compared a peer education intervention (PEI) with a time-matched, attention control group. Applying categorical latent variable analysis (mixture modeling) to baseline injection risk behavior data, we identified four distinct classes of injection-related HIV/HCV risk: low risk, non-syringe equipment-sharing, moderate-risk syringe-sharing, and high-risk syringe-sharing. The trial participation rate did not vary across classes. We conducted a latent transition analysis using trial baseline and 6-month follow-up data, to test the effect of the intervention on transitions to the low-risk class at follow-up. Adjusting for gender, age, and race/ethnicity, a significant intervention effect was found only for the high-risk class. Young IDU who exhibited high-risk behavior at baseline were 90 % more likely to be in the low-risk class at follow-up after the PEI intervention, compared to the control group.",
keywords = "HCV, HIV, Injection drug use, Intervention, Latent class analysis",
author = "MacKesy-Amiti, {Mary E.} and Lorna Finnegan and Ouellet, {Lawrence J.} and Golub, {Elizabeth T.} and Holly Hagan and Hudson, {Sharon M.} and Latka, {Mary H.} and Garfein, {Richard S.}",
note = "Funding Information: Acknowledgments This study was supported by a grant from the National Institute on Drug Abuse, R01 DA031584. The CIDUS-3/ DUIT intervention trial was supported by a cooperative agreement from the Centers for Disease Control and Prevention U64/ CCU317662, U64/CCU517656, U64/CCU917655, U64/CCU217659, U64/CCU017615; Institutional Review Board no. CDC-NCHSTP-2934. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute on Drug Abuse or the Centers for Disease Control and Prevention. The DUIT Study Group includes the following people: Steffanie Strathdee, Elizabeth Golub, Marie Bailey-Kloch and Karen Yen-Hobelman (Baltimore); Lawrence Ouellet, Susan Bailey and Joyce Fitzgerald (Chicago); Sharon Hudson, Peter Kerndt and Karla Wagner (Los Angeles); Mary Latka, David Vlahov and Farzana Kapadia (New York); Holly Hagan, Hanne Thiede, Nadine Snyder and Jennifer V. Campbell (Seattle); and Richard Garfein, David Purcell, Ian Williams, Paige Ingram and Andrea Swartzendruber (CDC). We thank Dr. Katie Witkiewitz for her expert assistance with the analysis.",
year = "2013",
month = jul,
doi = "10.1007/s10461-012-0373-0",
language = "English (US)",
volume = "17",
pages = "2075--2083",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "6",
}